Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Racial differences in neuromyelitis optica spectrum disorder.

Kim SH, Mealy MA, Levy M, Schmidt F, Ruprecht K, Paul F, Ringelstein M, Aktas O, Hartung HP, Asgari N, Tsz-Ching JL, Siritho S, Prayoonwiwat N, Shin HJ, Hyun JW, Han M, Leite MI, Palace J, Kim HJ.

Neurology. 2018 Oct 26. pii: 10.1212/WNL.0000000000006574. doi: 10.1212/WNL.0000000000006574. [Epub ahead of print]

PMID:
30366977
2.

Area postrema syndrome: Frequency, criteria, and severity in AQP4-IgG-positive NMOSD.

Shosha E, Dubey D, Palace J, Nakashima I, Jacob A, Fujihara K, Takahashi T, Whittam D, Leite MI, Misu T, Yoshiki T, Messina S, Elsone L, Majed M, Flanagan E, Gadoth A, Huebert C, Sagen J, Greenberg BM, Levy M, Banerjee A, Weinshenker B, Pittock SJ.

Neurology. 2018 Oct 23;91(17):e1642-e1651. doi: 10.1212/WNL.0000000000006392. Epub 2018 Sep 26.

PMID:
30258024
3.

Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study.

Oertel FC, Havla J, Roca-Fernández A, Lizak N, Zimmermann H, Motamedi S, Borisow N, White OB, Bellmann-Strobl J, Albrecht P, Ruprecht K, Jarius S, Palace J, Leite MI, Kuempfel T, Paul F, Brandt AU.

J Neurol Neurosurg Psychiatry. 2018 Jun 19. pii: jnnp-2018-318382. doi: 10.1136/jnnp-2018-318382. [Epub ahead of print]

PMID:
29921610
4.

Distinct HLA associations of LGI1 and CASPR2-antibody diseases.

Binks S, Varley J, Lee W, Makuch M, Elliott K, Gelfand JM, Jacob S, Leite MI, Maddison P, Chen M, Geschwind MD, Grant E, Sen A, Waters P, McCormack M, Cavalleri GL, Barnardo M, Knight JC, Irani SR.

Brain. 2018 May 18. doi: 10.1093/brain/awy109. [Epub ahead of print]

5.

High and low pressure headaches: a spinal cause.

Petkovic G, Rose-Innes E, Bojanic S, Leite MI, Wakerley BR.

Pract Neurol. 2018 Oct;18(5):413-414. doi: 10.1136/practneurol-2017-001769. Epub 2018 May 18. No abstract available.

PMID:
29777013
6.

To start immune therapy or not? An unusual presentation of longitudinally extensive transverse myelitis with pyrexia.

Rounis E, Leite MI, Pretorius PM, Sen A.

J Neurol. 2018 Jun;265(6):1463-1465. doi: 10.1007/s00415-018-8879-7. Epub 2018 May 3. No abstract available.

PMID:
29725838
7.

Ion channels in EEG: isolating channel dysfunction in NMDA receptor antibody encephalitis.

Symmonds M, Moran CH, Leite MI, Buckley C, Irani SR, Stephan KE, Friston KJ, Moran RJ.

Brain. 2018 Jun 1;141(6):1691-1702. doi: 10.1093/brain/awy107.

8.

Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica.

Wilson R, Makuch M, Kienzler AK, Varley J, Taylor J, Woodhall M, Palace J, Leite MI, Waters P, Irani SR.

Brain. 2018 Apr 1;141(4):1063-1074. doi: 10.1093/brain/awy010.

9.

Immune or Genetic-Mediated Disruption of CASPR2 Causes Pain Hypersensitivity Due to Enhanced Primary Afferent Excitability.

Dawes JM, Weir GA, Middleton SJ, Patel R, Chisholm KI, Pettingill P, Peck LJ, Sheridan J, Shakir A, Jacobson L, Gutierrez-Mecinas M, Galino J, Walcher J, Kühnemund J, Kuehn H, Sanna MD, Lang B, Clark AJ, Themistocleous AC, Iwagaki N, West SJ, Werynska K, Carroll L, Trendafilova T, Menassa DA, Giannoccaro MP, Coutinho E, Cervellini I, Tewari D, Buckley C, Leite MI, Wildner H, Zeilhofer HU, Peles E, Todd AJ, McMahon SB, Dickenson AH, Lewin GR, Vincent A, Bennett DL.

Neuron. 2018 Feb 21;97(4):806-822.e10. doi: 10.1016/j.neuron.2018.01.033. Epub 2018 Feb 8.

10.

Thymus imaging in myasthenia gravis: The relevance in clinical practice.

Klimiec E, Quirke M, Leite MI, Hilton-Jones D.

Muscle Nerve. 2018 Feb 9. doi: 10.1002/mus.26096. [Epub ahead of print]

PMID:
29424940
11.

N-methyl-D-aspartate receptor antibody production from germinal center reactions: Therapeutic implications.

Makuch M, Wilson R, Al-Diwani A, Varley J, Kienzler AK, Taylor J, Berretta A, Fowler D, Lennox B, Leite MI, Waters P, Irani SR.

Ann Neurol. 2018 Mar;83(3):553-561. doi: 10.1002/ana.25173.

12.

Thymoma-associated myasthenia gravis and LGI1-encephalitis, with nephrotic syndrome post-thymectomy.

Hor JY, Lim TT, Cheng MC, Chia YK, Wong CK, Lim SM, Cheah CF, Tan K, Easaw PES, Leite MI.

J Neuroimmunol. 2018 Apr 15;317:100-102. doi: 10.1016/j.jneuroim.2018.01.011. Epub 2018 Feb 1.

PMID:
29395322
13.

Serological and experimental studies in different forms of myasthenia gravis.

Vincent A, Huda S, Cao M, Cetin H, Koneczny I, Rodriguez-Cruz P, Jacobson L, Viegas S, Jacob S, Woodhall M, Nagaishi A, Maniaol A, Damato V, Leite MI, Cossins J, Webster R, Palace J, Beeson D.

Ann N Y Acad Sci. 2018 Feb;1413(1):143-153. doi: 10.1111/nyas.13592. Epub 2018 Jan 29. Review. Erratum in: Ann N Y Acad Sci. 2018 Apr;1417(1):130.

PMID:
29377162
14.

Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Hacohen Y, Wong YY, Lechner C, Jurynczyk M, Wright S, Konuskan B, Kalser J, Poulat AL, Maurey H, Ganelin-Cohen E, Wassmer E, Hemingway C, Forsyth R, Hennes EM, Leite MI, Ciccarelli O, Anlar B, Hintzen R, Marignier R, Palace J, Baumann M, Rostásy K, Neuteboom R, Deiva K, Lim M.

JAMA Neurol. 2018 Apr 1;75(4):478-487. doi: 10.1001/jamaneurol.2017.4601.

PMID:
29305608
15.

MuSK myasthenia gravis and pregnancy.

Santos E, Braga A, Gabriel D, Duarte S, Martins da Silva A, Matos I, Freijo M, Martins J, Silveira F, Nadais G, Sousa F, Fraga C, Santos Silva R, Lopes C, Gonçalves G, Pinto C, Sousa Braga J, Leite MI.

Neuromuscul Disord. 2018 Feb;28(2):150-153. doi: 10.1016/j.nmd.2017.11.014. Epub 2017 Nov 28.

PMID:
29305138
16.

The importance of early immunotherapy in patients with faciobrachial dystonic seizures.

Thompson J, Bi M, Murchison AG, Makuch M, Bien CG, Chu K, Farooque P, Gelfand JM, Geschwind MD, Hirsch LJ, Somerville E, Lang B, Vincent A, Leite MI, Waters P, Irani SR; Faciobrachial Dystonic Seizures Study Group .

Brain. 2018 Feb 1;141(2):348-356. doi: 10.1093/brain/awx323.

17.

A nationwide epidemiological study of myasthenia gravis in Latvia.

Zieda A, Ravina K, Glazere I, Pelcere L, Naudina MS, Liepina L, Kamsa I, Kurjane N, Woodhall M, Jacobson L, Leite MI, Tandon K, Kenina V.

Eur J Neurol. 2018 Mar;25(3):519-526. doi: 10.1111/ene.13535. Epub 2018 Jan 8.

PMID:
29194859
18.

Amiloride does not protect retinal nerve fibre layer thickness in optic neuritis in a phase 2 randomised controlled trial.

McKee JB, Cottriall CL, Elston J, Epps S, Evangelou N, Gerry S, Kennard C, Kong Y, Koelewyn A, Kueker W, Leite MI, Palace J, Craner M.

Mult Scler. 2017 Nov 1:1352458517742979. doi: 10.1177/1352458517742979. [Epub ahead of print]

PMID:
29172994
19.

Clinical presentation and prognosis in MOG-antibody disease: a UK study.

Jurynczyk M, Messina S, Woodhall MR, Raza N, Everett R, Roca-Fernandez A, Tackley G, Hamid S, Sheard A, Reynolds G, Chandratre S, Hemingway C, Jacob A, Vincent A, Leite MI, Waters P, Palace J.

Brain. 2017 Dec 1;140(12):3128-3138. doi: 10.1093/brain/awx276. No abstract available.

PMID:
29136091
20.

The Association of British Neurologists' myasthenia gravis guidelines.

Sussman J, Farrugia ME, Maddison P, Hill M, Leite MI, Hilton-Jones D.

Ann N Y Acad Sci. 2018 Jan;1412(1):166-169. doi: 10.1111/nyas.13503. Epub 2017 Nov 9.

PMID:
29121404
21.

Prevalence of neuromyelitis optica spectrum disorder in the multi-ethnic Penang Island, Malaysia, and a review of worldwide prevalence.

Hor JY, Lim TT, Chia YK, Ching YM, Cheah CF, Tan K, Chow HB, Arip M, Eow GB, Easaw PES, Leite MI.

Mult Scler Relat Disord. 2018 Jan;19:20-24. doi: 10.1016/j.msard.2017.10.015. Epub 2017 Oct 21. Review.

PMID:
29100047
22.

Myasthenia gravis with systemic and neurological polyautoimmunity.

Duarte S, Santos E, Martins J, Martins Silva A, Lopes C, Gonçalves G, Leite MI.

J Neurol Sci. 2017 Oct 15;381:39-40. doi: 10.1016/j.jns.2017.08.010. Epub 2017 Aug 9. No abstract available.

PMID:
28991712
23.

Endocrinopathies in paediatric-onset neuromyelitis optica spectrum disorder with aquaporin 4 (AQP4) antibody.

Hacohen Y, Messina S, Gan HW, Wright S, Chandratre S, Leite MI, Fallon P, Vincent A, Ciccarelli O, Wassmer E, Lim M, Palace J, Hemingway C.

Mult Scler. 2018 Apr;24(5):679-684. doi: 10.1177/1352458517726593. Epub 2017 Aug 14.

PMID:
28803524
24.

IgG-specific cell-based assay detects potentially pathogenic MuSK-Abs in seronegative MG.

Huda S, Waters P, Woodhall M, Leite MI, Jacobson L, De Rosa A, Maestri M, Ricciardi R, Heckmann JM, Maniaol A, Evoli A, Cossins J, Hilton-Jones D, Vincent A.

Neurol Neuroimmunol Neuroinflamm. 2017 Jun 5;4(4):e357. doi: 10.1212/NXI.0000000000000357. eCollection 2017 Jul.

25.

HLA and age of onset in myasthenia gravis.

Santos E, Bettencourt A, da Silva AM, Boleixa D, Lopes D, Brás S, Costa PPE, Lopes C, Gonçalves G, Leite MI, da Silva BM.

Neuromuscul Disord. 2017 Jul;27(7):650-654. doi: 10.1016/j.nmd.2017.04.002. Epub 2017 Apr 5.

PMID:
28495048
26.

Inflammatory myopathy associated with myasthenia gravis with and without thymic pathology: Report of four cases and literature review.

Santos E, Coutinho E, Martins da Silva A, Marinho A, Vasconcelos C, Taipa R, Pires MM, Gonçalves G, Lopes C, Leite MI.

Autoimmun Rev. 2017 Jun;16(6):644-649. doi: 10.1016/j.autrev.2017.04.009. Epub 2017 Apr 13.

PMID:
28414153
27.

Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis.

Jurynczyk M, Geraldes R, Probert F, Woodhall MR, Waters P, Tackley G, DeLuca G, Chandratre S, Leite MI, Vincent A, Palace J.

Brain. 2017 Mar 1;140(3):617-627. doi: 10.1093/brain/aww350.

PMID:
28364548
28.

Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies.

Lang B, Makuch M, Moloney T, Dettmann I, Mindorf S, Probst C, Stoecker W, Buckley C, Newton CR, Leite MI, Maddison P, Komorowski L, Adcock J, Vincent A, Waters P, Irani SR.

J Neurol Neurosurg Psychiatry. 2017 Apr;88(4):353-361. doi: 10.1136/jnnp-2016-314758. Epub 2017 Jan 23.

29.

Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease.

Juryńczyk M, Tackley G, Kong Y, Geraldes R, Matthews L, Woodhall M, Waters P, Kuker W, Craner M, Weir A, DeLuca GC, Kremer S, Leite MI, Vincent A, Jacob A, de Sèze J, Palace J.

J Neurol Neurosurg Psychiatry. 2017 Feb;88(2):132-136. doi: 10.1136/jnnp-2016-314005. Epub 2016 Oct 8.

PMID:
27951522
30.

Chronic neuropathic pain severity is determined by lesion level in aquaporin 4-antibody-positive myelitis.

Tackley G, Vecchio D, Hamid S, Jurynczyk M, Kong Y, Gore R, Mutch K, Woodhall M, Waters P, Vincent A, Leite MI, Tracey I, Jacob A, Palace J.

J Neurol Neurosurg Psychiatry. 2017 Feb;88(2):165-169. doi: 10.1136/jnnp-2016-314991. Epub 2016 Nov 24.

PMID:
27884934
31.

Pain in patients with transverse myelitis and its relationship to aquaporin 4 antibody status.

Kong Y, Okoruwa H, Revis J, Tackley G, Leite MI, Lee M, Tracey I, Palace J.

J Neurol Sci. 2016 Sep 15;368:84-8. doi: 10.1016/j.jns.2016.06.041. Epub 2016 Jun 23.

PMID:
27538606
32.

Neuromyelitis optica relapses: Race and rate, immunosuppression and impairment.

Tackley G, O'Brien F, Rocha J, Woodhall M, Waters P, Chandratre S, Halfpenny C, Hemingway C, Wassmer E, Wasiewski W, Leite MI, Palace J.

Mult Scler Relat Disord. 2016 May;7:21-5. doi: 10.1016/j.msard.2016.02.014. Epub 2016 Feb 16.

PMID:
27237752
33.

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica.

Waters P, Reindl M, Saiz A, Schanda K, Tuller F, Kral V, Nytrova P, Sobek O, Nielsen HH, Barington T, Lillevang ST, Illes Z, Rentzsch K, Berthele A, Berki T, Granieri L, Bertolotto A, Giometto B, Zuliani L, Hamann D, van Pelt ED, Hintzen R, Höftberger R, Costa C, Comabella M, Montalban X, Tintoré M, Siva A, Altintas A, Deniz G, Woodhall M, Palace J, Paul F, Hartung HP, Aktas O, Jarius S, Wildemann B, Vedeler C, Ruiz A, Leite MI, Trillenberg P, Probst M, Saschenbrecker S, Vincent A, Marignier R.

J Neurol Neurosurg Psychiatry. 2016 Sep;87(9):1005-15. doi: 10.1136/jnnp-2015-312601. Epub 2016 Apr 25.

34.

Epidemiology of myasthenia gravis in Northern Portugal: Frequency estimates and clinical epidemiological distribution of cases.

Santos E, Coutinho E, Moreira I, Silva AM, Lopes D, Costa H, Silveira F, Nadais G, Morais H, Martins J, Branco MC, Veiga A, Silva RS, Ferreira A, Sousa F, Freijo M, Matos I, André R, Negrão L, Fraga C, Santos M, Sampaio M, Lopes C, Leite MI, Gonçalves G.

Muscle Nerve. 2016 Sep;54(3):413-21. doi: 10.1002/mus.25068. Epub 2016 Jul 4.

PMID:
26851892
35.

Author's Response:.

Symmonds M, Leite MI, Schulz UG.

Neurology. 2015 Oct 6;85(14):1263. No abstract available.

PMID:
26716145
36.

Isolated new onset 'atypical' optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up.

Piccolo L, Woodhall M, Tackley G, Juryńczyk M, Kong Y, Domingos J, Gore R, Vincent A, Waters P, Leite MI, Palace J.

J Neurol. 2016 Feb;263(2):370-379. doi: 10.1007/s00415-015-7983-1. Epub 2015 Dec 14.

PMID:
26668077
37.

Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.

Nour MM, Nakashima I, Coutinho E, Woodhall M, Sousa F, Revis J, Takai Y, George J, Kitley J, Santos ME, Nour JM, Cheng F, Kuroda H, Misu T, Martins-da-Silva A, DeLuca GC, Vincent A, Palace J, Waters P, Fujihara K, Leite MI.

Neurology. 2016 Jan 5;86(1):79-87. doi: 10.1212/WNL.0000000000002208. Epub 2015 Nov 18.

38.

Antibodies to aquaporin-1 are not present in neuromyelitis optica.

Schanda K, Waters P, Holzer H, Aboulenein-Djamshidian F, Leite MI, Palace J, Vukusic S, Marignier R, Berger T, Reindl M.

Neurol Neuroimmunol Neuroinflamm. 2015 Oct 1;2(6):e160. doi: 10.1212/NXI.0000000000000160. eCollection 2015 Dec. No abstract available.

39.

Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple Sclerosis.

Matthews L, Kolind S, Brazier A, Leite MI, Brooks J, Traboulsee A, Jenkinson M, Johansen-Berg H, Palace J.

PLoS One. 2015 Sep 18;10(9):e0137715. doi: 10.1371/journal.pone.0137715. eCollection 2015.

40.

Congenital myasthenic syndrome due to mutation in CHRNE gene with clinical worsening and thymic hyperplasia attributed to association with autoimmune-myasthenia gravis.

Santos E, Moreira I, Coutinho E, Gonçalves G, Lopes C, Lopes Lima J, Leite MI.

Neuromuscul Disord. 2015 Dec;25(12):928-31. doi: 10.1016/j.nmd.2015.08.001. Epub 2015 Aug 6.

PMID:
26363966
41.

Update on biomarkers in neuromyelitis optica.

Melamed E, Levy M, Waters PJ, Sato DK, Bennett JL, John GR, Hooper DC, Saiz A, Bar-Or A, Kim HJ, Pandit L, Leite MI, Asgari N, Kissani N, Hintzen R, Marignier R, Jarius S, Marcelletti J, Smith TJ, Yeaman MR, Han MH, Aktas O, Apiwattanakul M, Banwell B, Bichuetti D, Broadley S, Cabre P, Chitnis T, De Seze J, Fujihara K, Greenberg B, Hellwig K, Iorio R, Jarius S, Klawiter E, Kleiter I, Lana-Peixoto M, Nakashima, O'Connor K, Palace J, Paul F, Prayoonwiwat N, Ruprecht K, Stuve O, Tedder T, Tenembaum S, Garrahan JP, Aires B, van Herle K, van Pelt D, Villoslada P, Waubant E, Weinshenker B, Wingerchuk D, Würfel J, Zamvil S.

Neurol Neuroimmunol Neuroinflamm. 2015 Jul 23;2(4):e134. doi: 10.1212/NXI.0000000000000134. eCollection 2015 Aug. Review.

42.

Aquaporin-4 antibody isoform binding specificities do not explain clinical variations in NMO.

Kitley J, Woodhall M, Leite MI, Palace J, Vincent A, Waters P.

Neurol Neuroimmunol Neuroinflamm. 2015 Jun 18;2(4):e121. doi: 10.1212/NXI.0000000000000121. eCollection 2015 Aug.

43.

Predictive value of MRI parameters in severity and recovery of first-episode myelitis in aquaporin-4 antibody disease.

Murchison A, Kitley J, Leite MI, Küker W, Palace J.

J Neurol Sci. 2015 Aug 15;355(1-2):49-53. doi: 10.1016/j.jns.2015.05.011. Epub 2015 May 16.

PMID:
26026944
44.

Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder.

Kremer S, Renard F, Achard S, Lana-Peixoto MA, Palace J, Asgari N, Klawiter EC, Tenembaum SN, Banwell B, Greenberg BM, Bennett JL, Levy M, Villoslada P, Saiz A, Fujihara K, Chan KH, Schippling S, Paul F, Kim HJ, de Seze J, Wuerfel JT; Guthy-Jackson Charitable Foundation (GJCF) Neuromyelitis Optica (NMO) International Clinical Consortium and Biorepository, Cabre P, Marignier R, Tedder T, van Pelt D, Broadley S, Chitnis T, Wingerchuk D, Pandit L, Leite MI, Apiwattanakul M, Kleiter I, Prayoonwiwat N, Han M, Hellwig K, van Herle K, John G, Hooper DC, Nakashima I, Sato D, Yeaman MR, Waubant E, Zamvil S, Stüve O, Aktas O, Smith TJ, Jacob A, O'Connor K.

JAMA Neurol. 2015 Jul;72(7):815-22. doi: 10.1001/jamaneurol.2015.0248. Review.

45.

Whippits, nitrous oxide and the dangers of legal highs.

Thompson AG, Leite MI, Lunn MP, Bennett DL.

Pract Neurol. 2015 Jun;15(3):207-9. doi: 10.1136/practneurol-2014-001071.

46.

Myasthenia gravis: Association of British Neurologists' management guidelines.

Sussman J, Farrugia ME, Maddison P, Hill M, Leite MI, Hilton-Jones D.

Pract Neurol. 2015 Jun;15(3):199-206. doi: 10.1136/practneurol-2015-001126. Review.

PMID:
25977271
47.

Demographic and clinical features of neuromyelitis optica: A review.

Pandit L, Asgari N, Apiwattanakul M, Palace J, Paul F, Leite MI, Kleiter I, Chitnis T; GJCF International Clinical Consortium & Biorepository for Neuromyelitis Optica.

Mult Scler. 2015 Jun;21(7):845-53. doi: 10.1177/1352458515572406. Epub 2015 Apr 28. Review.

48.

Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis.

Rodríguez Cruz PM, Al-Hajjar M, Huda S, Jacobson L, Woodhall M, Jayawant S, Buckley C, Hilton-Jones D, Beeson D, Vincent A, Leite MI, Palace J.

JAMA Neurol. 2015 Jun;72(6):642-9. doi: 10.1001/jamaneurol.2015.0203.

49.

MOG cell-based assay detects non-MS patients with inflammatory neurologic disease.

Waters P, Woodhall M, O'Connor KC, Reindl M, Lang B, Sato DK, Juryńczyk M, Tackley G, Rocha J, Takahashi T, Misu T, Nakashima I, Palace J, Fujihara K, Leite MI, Vincent A.

Neurol Neuroimmunol Neuroinflamm. 2015 Mar 19;2(3):e89. doi: 10.1212/NXI.0000000000000089. eCollection 2015 Jun.

50.

A 41-year-old woman with acute weakness and encephalopathy associated with MOG antibodies.

Morris KA, Waters P, Woodhall MR, Kuker W, Vincent A, Leite MI, Sen A.

Neurol Neuroimmunol Neuroinflamm. 2015 Mar 19;2(3):e88. doi: 10.1212/NXI.0000000000000088. eCollection 2015 Jun. No abstract available.

Supplemental Content

Loading ...
Support Center